RE:RE:RE:RE:RE:RE:results are goodI somehow felt that this clinical test result is realistic or close to realistic about 8 to 9 years ago. It took us this long, and with so much delays in between. We have had many screw ups during this time. The first one was when SEC decided to jump in on some (in my opinion flimsy) grounds and created a ruling that the founder of the company can not run the company for 5 years till Feb, 2023 (if I remember correct). The second major one is that the Bladder volume was not calculated correctly and a wrong (diluted) dose was administered, This in my opinion is the biggest f...up. (not including the 2 to 3 year delays due to COVID which no one could have anticipated)
Well all that is water under the bridge now. I have not sold a single share during this period and I believe we are in for a really good run up from here. Break through Designation is not only realistic, I think it is inevitable given the current data and comparable clinical tests being done in this area of research. Also keep in mind, this cure is not only effective, it is well tolerated and has the least amount of known adverse effects!!!.
My investment in TLT was the result of a very close call with the Urology department and the admirable work done by UHN Doctors and nurses. As bonus, I guess Santa is backing up his sled to load up for all the TLT stock holders!!! Happy Holidays every one...